We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

84 hedge funds and large institutions have $31.7M invested in Tempest Therapeutics in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

5% more funds holding

Funds holding: 80 → 84 (+4)

85% less capital invested

Capital invested by funds: $206M → $31.7M (-$175M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $38K

Holders
84
Holders Change
+4
Holders Change %
+5%
% of All Funds
2.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
21
Reduced
13
Closed
16
Calls
–
Puts
$38K
Net Calls
-$38K
Net Calls Change
+$49K

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$1.77M
2
Millennium Management
Millennium Management
New York
+$1.57M
3
Tudor Investment Corp
Tudor Investment Corp
Connecticut
+$1.32M
4
Morgan Stanley
Morgan Stanley
New York
+$473K
5
AIC
AWM Investment Company
New York
+$424K

Top Sellers

Rank Fund Capital Flow
1
OAG
Orbis Allan Gray
Bermuda
-$18.9M
2
JHIU
Janus Henderson Investors US
Colorado
-$16.4M
3
ACH
ArrowMark Colorado Holdings
Colorado
-$12.1M
4
Jennison Associates
Jennison Associates
New York
-$3.31M
5
Asset Management One
Asset Management One
Japan
-$2.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$53K -$37.4K -3 -20%
JHIU
52
Janus Henderson Investors US
Colorado
$47K -$16.4M -1,313 -99%
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$43K – – –
WS
54
Wedbush Securities
California
$42K +$112K +9 New
AIM
55
Acrospire Investment Management
Illinois
$36K +$99.7K +8 New
ZIM
56
Zacks Investment Management
Illinois
$36K +$99.7K +8 New
Dimensional Fund Advisors
57
Dimensional Fund Advisors
Texas
$33K – – –
NFA
58
Nationwide Fund Advisors
Ohio
$31K – – –
Squarepoint
59
Squarepoint
New York
$30K +$87.2K +7 New
AIG
60
American International Group
New York
$28K – – –
TC
61
TFS Capital
Pennsylvania
$27K +$74.7K +6 New
BA
62
BlackRock Advisors
Delaware
$26K – – –
PP
63
Paloma Partners
Connecticut
$25K +$74.7K +6 New
VOYA Investment Management
64
VOYA Investment Management
Georgia
$24K – – –
Barclays
65
Barclays
United Kingdom
$19K +$49.8K +4 New
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$18K – – –
TSS
67
Two Sigma Securities
New York
$16K +$37.4K +3 New
Citadel Advisors
68
Citadel Advisors
Florida
$16K +$49.8K +4 New
BG
69
BlackRock Group
United Kingdom
$14K – – –
UBS Group
70
UBS Group
Switzerland
$14K – – –
Group One Trading
71
Group One Trading
Illinois
$13K +$37.4K +3 New
Bank of America
72
Bank of America
North Carolina
$12K -$74.7K -6 -67%
Manulife (Manufacturers Life Insurance)
73
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$10K -$74.7K -6 -75%
BlackRock
74
BlackRock
New York
$10K – – –
Legal & General Group
75
Legal & General Group
United Kingdom
$10K – – –
1 2
3
4 5

TPST Hedge Fund Activity: Q4 2016 in Review

84 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q4 2016, worth a combined $31.7M — down 85% from $206M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TPST positions and 16 closed out — a net gain of 4 holders — while 21 added to existing stakes and 13 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $1.77M. The largest seller was Orbis Allan Gray, exiting entirely with an estimated $18.9M sold.

  • 84 institutional investors held Tempest Therapeutics (TPST) as of Q4 2016, up from 80 in Q3 2016.
  • Funds reported $31.7M of Tempest Therapeutics stock for Q4 2016, down 85% quarter-over-quarter.
  • 20 funds opened new Tempest Therapeutics positions in Q4 2016 and 16 closed out, a net change of +4 holders.
  • The largest Tempest Therapeutics buyer in Q4 2016 was Anson Funds Management, an estimated $1.77M added.
  • The largest Tempest Therapeutics seller in Q4 2016 was Orbis Allan Gray, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2016.